Slow Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.26M | Sell |
11,814
-20
| -0.2% | -$8.9K | 0.64% | 44 |
|
|
2025
Q1 | $5.74M | Buy |
11,834
+198
| +2% | +$96K | 0.77% | 37 |
|
|
2024
Q4 | $4.69M | Sell |
11,636
-1,003
| -8% | -$404K | 0.66% | 38 |
|
|
2024
Q3 | $5.88M | Sell |
12,639
-26
| -0.2% | -$12.1K | 0.9% | 27 |
|
|
2024
Q2 | $5.94M | Sell |
12,665
-245
| -2% | -$115K | 0.96% | 21 |
|
|
2024
Q1 | $5.4M | Sell |
12,910
-87
| -0.7% | -$36.4K | 0.86% | 25 |
|
|
2023
Q4 | $5.29M | Buy |
12,997
+51
| +0.4% | +$20.8K | 0.92% | 21 |
|
|
2023
Q3 | $4.5M | Buy |
12,946
+690
| +6% | +$240K | 0.83% | 26 |
|
|
2023
Q2 | $4.31M | Sell |
12,256
-733
| -6% | -$258K | 0.75% | 30 |
|
|
2023
Q1 | $4.09M | Buy |
12,989
+2,809
| +28% | +$885K | 0.77% | 33 |
|
|
2022
Q4 | $2.94M | Sell |
10,180
-264
| -3% | -$76.2K | 0.65% | 45 |
|
|
2022
Q3 | $3.02M | Buy |
10,444
+283
| +3% | +$81.9K | 0.65% | 35 |
|
|
2022
Q2 | $2.86M | Sell |
10,161
-480
| -5% | -$135K | 0.7% | 41 |
|
|
2022
Q1 | $2.78M | Sell |
10,641
-636
| -6% | -$166K | 0.52% | 56 |
|
|
2021
Q4 | $2.48M | Sell |
11,277
-4,111
| -27% | -$903K | 0.42% | 86 |
|
|
2021
Q3 | $2.79M | Sell |
15,388
-44
| -0.3% | -$7.98K | 0.51% | 67 |
|
|
2021
Q2 | $3.11M | Buy |
15,432
+3,033
| +24% | +$612K | 0.59% | 56 |
|
|
2021
Q1 | $2.73M | Buy |
12,399
+1,841
| +17% | +$405K | 0.59% | 58 |
|
|
2020
Q4 | $2.5M | Buy |
10,558
+2,408
| +30% | +$569K | 0.6% | 52 |
|
|
2020
Q3 | $2.22M | Buy |
8,150
+564
| +7% | +$153K | 0.6% | 54 |
|
|
2020
Q2 | $2.2M | Buy |
7,586
+135
| +2% | +$39.2K | 0.65% | 47 |
|
|
2020
Q1 | $1.77M | Buy |
7,451
+695
| +10% | +$165K | 0.67% | 50 |
|
|
2019
Q4 | $1.48M | Sell |
6,756
-246
| -4% | -$53.9K | 0.46% | 77 |
|
|
2019
Q3 | $1.19M | Buy |
7,002
+2,881
| +70% | +$488K | 0.42% | 93 |
|
|
2019
Q2 | $756K | Buy |
+4,121
| New | +$756K | 0.31% | 102 |
|